Clinical Trial Update: 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme [NA]

View source ↗

Summary

A completed clinical trial evaluating 89Zr-J591 anti-PSMA antibody in patients with glioblastoma multiforme; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 89Zr-J591 (89Zr-J591)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioblastoma | NA | Status: COMPLETED | Results posted: 2019-03-19